Houssein Abdul Sater MD

Dr. Sater is a translational physician-scientist (hematologist/oncologist) with a special interest in immune therapy of cancer. He leads the Genitourinary Malignancies Branch efforts at understanding the role of cancer immunotherapy on the tumor (immune and non-immune) micro-environment. Dr. Sater is one of the few nationally recognized experts in tissue-based multiplex biomarker development and multispectral imaging. The Society of Immune Therapy of Cancer (SITC) chose him as one of 29 young leader investigators to tackle one of the major hurdles in immune therapy in a funded consortium effort (Sparkathon Timios Project). He also has an interest in demographics (gender, race, age, BMI) effect on immune therapy as a biomarker for better-personalized medicine.